See more : Jack Creek Investment Corp. (JCIC) Income Statement Analysis – Financial Results
Complete financial analysis of Avisa Diagnostics Inc. (FOGCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avisa Diagnostics Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Gold Digger Resources Inc. (GDIG.CN) Income Statement Analysis – Financial Results
- Svenska Handelsbanken AB (publ) (SHB-B.ST) Income Statement Analysis – Financial Results
- Century Ginwa Retail Holdings Limited (0162.HK) Income Statement Analysis – Financial Results
- Giyani Metals Corp. (CATPF) Income Statement Analysis – Financial Results
- PT Wilmar Cahaya Indonesia Tbk. (CEKA.JK) Income Statement Analysis – Financial Results
Avisa Diagnostics Inc. (FOGCF)
About Avisa Diagnostics Inc.
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Santa Fe, New Mexico.
| Metric | 2020 | 2019 |
|---|---|---|
| Revenue | 277.83K | 858.36K |
| Cost of Revenue | 148.55K | 2.80M |
| Gross Profit | 129.28K | -1.94M |
| Gross Profit Ratio | 46.53% | -226.57% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 859.98K | 0.00 |
| Selling & Marketing | 3.56K | 0.00 |
| SG&A | 863.53K | 787.19K |
| Other Expenses | 166.40K | 0.00 |
| Operating Expenses | 1.03M | 787.19K |
| Cost & Expenses | 1.18M | 3.59M |
| Interest Income | 523.25 | 2.05K |
| Interest Expense | 17.10K | 0.00 |
| Depreciation & Amortization | 21.08K | 988.12K |
| EBITDA | -678.64K | -3.24M |
| EBITDA Ratio | -244.26% | -203.16% |
| Operating Income | -900.66K | -2.73M |
| Operating Income Ratio | -324.17% | -318.28% |
| Total Other Income/Expenses | 184.89K | -1.03M |
| Income Before Tax | -715.76K | -4.23M |
| Income Before Tax Ratio | -257.63% | -492.80% |
| Income Tax Expense | 0.00 | -2.05K |
| Net Income | -715.76K | -4.23M |
| Net Income Ratio | -257.63% | -492.80% |
| EPS | -0.14 | -0.86 |
| EPS Diluted | -0.14 | -0.86 |
| Weighted Avg Shares Out | 5.22M | 4.92M |
| Weighted Avg Shares Out (Dil) | 5.22M | 4.92M |
Source: https://incomestatements.info
Category: Stock Reports